Showing 1071-1080 of 5603 results for "".
Conquer the Clutter: Strategies to Identify, Manage, & Overcome Hoarding
https://reachmd.com/programs/book-club/conquer-the-clutter-strategies-to-identify-manage-overcome-hoarding/11245/As many as 21 million Americans may be living with hoarding disorder. How can we help them reclaim their lives from the clutter that’s taken over?Surgical Management of Epilepsy in Older Adults: Focus on Neurostimulation and Neuromodulation
https://reachmd.com/diseases-diagnoses/epilepsy-seizures/surgical-management-of-epilepsy-in-older-adults-focus-on-neurostimulation-and-neuromodulation/32177/Recent developments in surgical epilepsy, especially minimally invasive procedures and neuromodulatory devices, may be particularly useful in the management of drug-resistant epilepsy in older adults.One Emergency Physician’s Cheat Sheet to COVID-19
https://reachmd.com/programs/covid-19-frontlines/one-emergency-physicians-cheat-sheet-to-covid-19/11376/Tune in to hear an anonymous account of unpredictable COVID-19 symptoms in a small-town emergency room.Death Rates in the United States Continue to Decrease
https://reachmd.com/programs/the-jama-report/death-rates-united-states-continue-decrease/7731/[Read the Article] Evaluating long-term trends in mortality is important for health planning, priority setting and also to identify modifiable factors contributing to poor health. In a new study, researchers from the American Cancer Society reviewed changes in the overall U.S. death rate, as well asRethinking MacTel: Cell-based Insights for Vision Preservation
https://reachmd.com/programs/cme/Rethinking-MacTel-Cell-Based-Insights-for-Vision-Preservation/35524/Catch up on the latest information on the management of macular telangiectasia type 2 (MacTel) with a new encapsulated cell therapy, revakinagene taroretcel.EMPOWER Study Exposes Major Gaps in Epilepsy Management
https://reachmd.com/programs/practical-neurology/empower-study-exposes-major-gaps-in-epilepsy-management/49195/Identifying and Managing Adult Patients with Chronic Immune Thrombocytopenia
https://reachmd.com/programs/medical-industry-feature/adult-chronic-immune-thrombocytopenia-management/56537/Chronic immune thrombocytopenia (ITP) is an autoimmune disorder characterized by low platelet counts and increased bleeding risk, and can have significant impacts on patients’ quality of life.1 Treatment decisions require a personalized approach that considers both clinical factors and patient prefeEvaluating EFS and Surgical Outcomes in Resectable NSCLC: Insights From a Clinical Trial
https://reachmd.com/programs/medical-industry-feature/evaluating-efs-and-surgical-outcomes-in-resectable-nsclc-insights-from-a-clinical-trial/39813/Medical Advances in Women's Health: A Look at the Past 10 Years
https://reachmd.com/programs/clinicians-roundtable/medical-advances-in-womens-health-a-look-at-the-past-10-years/7007/In this program, senior correspondent Ana Maria Rosario chats with Drs. Andrea Singer andThomas C. Wright Jr. to review medical breakthroughs over the past 10 years in the field of women's health. Their discussion specifically focuses on cardiovascular medicine; advances in HPV; updates on female seOff-Label Medicines in Fighting COVID-19 & Through the Years
https://reachmd.com/programs/covid-19-frontlines/off-label-medicines-in-fighting-covid-19-through-the-years/11417/In hospitals across the country, doctors are using old malarial medicines to help battle COVID-19. But how did this even dawn on anyone to try it?